Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NVO
NVO logo

NVO News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NVO News

Japan Approves Wegovy for Liver Disease Treatment

12h agoNASDAQ.COM

Novo Nordisk Launches CardioMetabolic Bridge to Advance Obesity Research

9h agoYahoo Finance

Zealand Pharma Shares Plunge 23% Amid Survodutide Concerns

21h agoCNBC

Zealand Pharma Faces Setbacks, Analysts Reassess Obesity Drug Strategy

21h agoNewsfilter

Hims & Hers Partners with Novo Nordisk, Boosting Stock Momentum

2d agostocktwits

Recap of CNBC Investing Club Monthly Meeting

2d agoCNBC

Novo Nordisk to File for Wegovy Approval in China Soon

2d agoseekingalpha

FDA Issues Warning Letters to Telehealth Firms Over Misleading GLP-1 Claims

2d agoseekingalpha

NVO Events

06/17 12:30
Novo Nordisk Shares Rise 1.96% to $44.41
Moderately bullish activity in Novo Nordisk (NVO), with shares up 86c, or 1.96%, near $44.41. Options volume relatively light with 25k contracts traded and calls leading puts for a put/call ratio of 0.54, compared to a typical level near 0.57. Implied volatility (IV30) is higher by 0.2 points near 35.72,in the lowest 10% of observations over the past year, suggesting an expected daily move of $1.00. Put-call skew steepened, indicating increased demand for downside protection.

NVO Monitor News

Novo Nordisk's CagriSema Phase 3 Trials Show Positive Results

Jun 08 2026

Novo Nordisk Launches Wegovy in UAE Following Approval

Jun 04 2026

Novo Nordisk Faces Competition Despite Wegovy Growth

Jun 02 2026

Novo Nordisk raises profit guidance amid strong Wegovy demand

May 11 2026

Novo Nordisk's Wegovy Drives Growth in GLP-1 Drug Market

May 06 2026

FDA Proposal May Impact Novo Nordisk's Obesity Drug Market

May 01 2026

Novo Nordisk partners with OpenAI to enhance drug development

Apr 30 2026

Novo Nordisk Plans U.S. Launch of Oral Ozempic After Successful Trial

Apr 24 2026

NVO Earnings Analysis

Novo Nordisk Reports Strong H1 2025 Earnings, Obesity Growth- Intellectia AI™
10 months ago

People Also Watch